553 related articles for article (PubMed ID: 14998334)
1. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.
Boswell CA; Sun X; Niu W; Weisman GR; Wong EH; Rheingold AL; Anderson CJ
J Med Chem; 2004 Mar; 47(6):1465-74. PubMed ID: 14998334
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
Sun X; Wuest M; Weisman GR; Wong EH; Reed DP; Boswell CA; Motekaitis R; Martell AE; Welch MJ; Anderson CJ
J Med Chem; 2002 Jan; 45(2):469-77. PubMed ID: 11784151
[TBL] [Abstract][Full Text] [Related]
3. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.
Sprague JE; Peng Y; Sun X; Weisman GR; Wong EH; Achilefu S; Anderson CJ
Clin Cancer Res; 2004 Dec; 10(24):8674-82. PubMed ID: 15623652
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling.
Boswell CA; Regino CA; Baidoo KE; Wong KJ; Bumb A; Xu H; Milenic DE; Kelley JA; Lai CC; Brechbiel MW
Bioconjug Chem; 2008 Jul; 19(7):1476-84. PubMed ID: 18597510
[TBL] [Abstract][Full Text] [Related]
5. Isomeric trimethylene and ethylene pendant-armed cross-bridged tetraazamacrocycles and in vitro/in vivo comparisions of their copper(II) complexes.
Odendaal AY; Fiamengo AL; Ferdani R; Wadas TJ; Hill DC; Peng Y; Heroux KJ; Golen JA; Rheingold AL; Anderson CJ; Weisman GR; Wong EH
Inorg Chem; 2011 Apr; 50(7):3078-86. PubMed ID: 21381676
[TBL] [Abstract][Full Text] [Related]
6. Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS.
Boswell CA; McQuade P; Weisman GR; Wong EH; Anderson CJ
Nucl Med Biol; 2005 Jan; 32(1):29-38. PubMed ID: 15691659
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents.
Sprague JE; Peng Y; Fiamengo AL; Woodin KS; Southwick EA; Weisman GR; Wong EH; Golen JA; Rheingold AL; Anderson CJ
J Med Chem; 2007 May; 50(10):2527-35. PubMed ID: 17458949
[TBL] [Abstract][Full Text] [Related]
8. In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands.
Sun X; Wuest M; Kovacs Z; Sherry AD; Motekaitis R; Wang Z; Martell AE; Welch MJ; Anderson CJ
J Biol Inorg Chem; 2003 Jan; 8(1-2):217-25. PubMed ID: 12459917
[TBL] [Abstract][Full Text] [Related]
9. Comparative Assessment of Complex Stabilities of Radiocopper Chelating Agents by a Combination of Complex Challenge and in vivo Experiments.
Litau S; Seibold U; Vall-Sagarra A; Fricker G; Wängler B; Wängler C
ChemMedChem; 2015 Jul; 10(7):1200-8. PubMed ID: 26011290
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms.
Ferdani R; Stigers DJ; Fiamengo AL; Wei L; Li BT; Golen JA; Rheingold AL; Weisman GR; Wong EH; Anderson CJ
Dalton Trans; 2012 Feb; 41(7):1938-50. PubMed ID: 22170043
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vivo behavior studies of cyclen-based copper-64 complexes: regioselective synthesis, X-ray structure, radiochemistry, log P, and biodistribution.
Yoo J; Reichert DE; Welch MJ
J Med Chem; 2004 Dec; 47(26):6625-37. PubMed ID: 15588098
[TBL] [Abstract][Full Text] [Related]
12. Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.
Guo Y; Ferdani R; Anderson CJ
Bioconjug Chem; 2012 Jul; 23(7):1470-7. PubMed ID: 22663248
[TBL] [Abstract][Full Text] [Related]
13. Investigation of copper-azamacrocyclic complexes by high-performance liquid chromatography.
Shen X; Boswell CA; Wong EH; Weisman GR; Anderson CJ; Tomellini SA
Biomed Chromatogr; 2006 Jan; 20(1):37-47. PubMed ID: 15954159
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.
Kumar SR; Gallazzi FA; Ferdani R; Anderson CJ; Quinn TP; Deutscher SL
Cancer Biother Radiopharm; 2010 Dec; 25(6):693-703. PubMed ID: 21204764
[TBL] [Abstract][Full Text] [Related]
15. Click-chemistry strategy for labeling antibodies with copper-64 via a cross-bridged tetraazamacrocyclic chelator scaffold.
Kumar A; Hao G; Liu L; Ramezani S; Hsieh JT; Öz OK; Sun X
Bioconjug Chem; 2015 Apr; 26(4):782-9. PubMed ID: 25760776
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator.
Wei L; Butcher C; Miao Y; Gallazzi F; Quinn TP; Welch MJ; Lewis JS
J Nucl Med; 2007 Jan; 48(1):64-72. PubMed ID: 17204700
[TBL] [Abstract][Full Text] [Related]
17. The in vivo behavior of copper-64-labeled azamacrocyclic complexes.
Jones-Wilson TM; Deal KA; Anderson CJ; McCarthy DW; Kovacs Z; Motekaitis RJ; Sherry AD; Martell AE; Welch MJ
Nucl Med Biol; 1998 Aug; 25(6):523-30. PubMed ID: 9751418
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64.
Jensen AI; Binderup T; Kumar EK P; Kjær A; Rasmussen PH; Andresen TL
Biomacromolecules; 2014 May; 15(5):1625-33. PubMed ID: 24645913
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers.
Dale AV; An GI; Pandya DN; Ha YS; Bhatt N; Soni N; Lee H; Ahn H; Sarkar S; Lee W; Huynh PT; Kim JY; Gwon MR; Kim SH; Park JG; Yoon YR; Yoo J
Inorg Chem; 2015 Sep; 54(17):8177-86. PubMed ID: 26286436
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64.
Wadas TJ; Anderson CJ
Nat Protoc; 2006; 1(6):3062-8. PubMed ID: 17406569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
